New Key Statistics Module, Z-Score and F-Score
NAS:PRME Key Ratios
| Market Cap $ M | 487.93 |
| Enterprise Value $ M | 355.24 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.48 |
| Price/Sales | 675.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.17 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.71 |
| EV-to-EBITDA | -1.76 |
| PEG | -- |
| Shares Outstanding M | 120.03 |
| Net Margin (%) | -36,791.71 |
| Operating Margin % | -35,535.53 |
| Pre-tax Margin (%) | -36,809.98 |
| Quick Ratio | 8.23 |
| Current Ratio | 8.23 |
| ROA % (ttm) | -84.61 |
| ROE % (ttm) | -107.91 |
| ROIC % (ttm) | -245.18 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.66 |
PRME Number of Guru Trades
PRME Volume of Guru Trades
Gurus Latest Trades with NAS:PRME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRME is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Prime Medicine Inc Insider Transactions
No Available Data
News about NAS:PRME
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers